Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D05AOH
|
||||
Former ID |
DNC011923
|
||||
Drug Name |
1-Iodyl-3-nitro-benzene
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [525449] | ||
Structure |
Download2D MOL |
||||
Formula |
C6H4INO4
|
||||
Canonical SMILES |
C1=CC(=CC(=C1)I(=O)=O)[N+](=O)[O-]
|
||||
InChI |
1S/C6H4INO4/c9-7(10)5-2-1-3-6(4-5)8(11)12/h1-4H
|
||||
InChIKey |
PSLSYWRHLJIBMS-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | mRNA of Protein tyrosine phosphatase-1B | Target Info | Inhibitor | [525449] | |
KEGG Pathway | Adherens junction | ||||
Insulin signaling pathway | |||||
NetPath Pathway | FSH Signaling Pathway | ||||
PANTHER Pathway | Cadherin signaling pathway | ||||
Pathway Interaction Database | Insulin Pathway | ||||
Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) | |||||
Signaling events mediated by PTP1B | |||||
Calcineurin-regulated NFAT-dependent transcription in lymphocytes | |||||
Signaling events mediated by TCPTP | |||||
IGF1 pathway | |||||
EGF receptor (ErbB1) signaling pathway | |||||
Posttranslational regulation of adherens junction stability and dissassembly | |||||
PDGFR-beta signaling pathway | |||||
N-cadherin signaling events | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.